RGD Reference Report - Effects of recombinant human growth hormone (r-hGH) on experimental osteoporotic fracture healing. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Effects of recombinant human growth hormone (r-hGH) on experimental osteoporotic fracture healing.

Authors: Hao, Y  Dai, K  Guo, L  Wang, Y  Tang, T 
Citation: Hao Y, etal., Chin J Traumatol. 2001 May;4(2):102-5.
RGD ID: 10003137
Pubmed: PMID:11834155   (View Abstract at PubMed)

OBJECTIVE: To observe the effect of recombinant human growth hormone (r-hGH) on osteoporotic fracture healing in rats, and to provide an effective therapy for osteoporotic fracture. METHODS: Thirty-six female 8-month-old SD rats were randomized into two groups: therapy group and control group. After the experimental model of osteoporotic fracture was established, the therapy group was treated with r-hGH of 2.7 mg/kg body weigh/day (1 mg=3 IU) for 10 days continuously by daily subcutaneous injection; whereas the control group was treated with equivalent saline. Plasma insulin-like growth factor I concentration was detected and bone mineral density (BMD) as well as biomechanical strength of callus were measured at 2, 4, 8 weeks. RESULTS: Plasma insulin-like growth factor I concentration in the therapy group was higher than that in the control group (P<0.005) at 2nd week and began to decline at 4th week. At 8th week, there was no significant difference between the two groups. At 4th week, callus area and BMD in therapy group were higher than those in the control group, but at 8th week, they were lower and BMD had a significant difference between the two groups (P<0.001). Biomechanical testing of callus showed that torsional strength of the therapy group was higher than that of the control group at 4th or 8th week, meanwhile maximum torsional angle had a significant difference between the two groups (P<0.005). CONCLUSIONS: The results show that exogenous r-hGH can stimulate osteoporotic fracture healing in rats.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
Osteoporotic Fractures treatmentIDA 10003137; 10003137 RGD 
Osteoporotic Fractures treatmentISOGH1 (Homo sapiens)10003137; 10003137 RGD 
Osteoporotic Fractures treatmentISOIgf1 (Rattus norvegicus)10003137; 10003137 RGD 

Objects Annotated

Genes (Rattus norvegicus)
Gh1  (growth hormone 1)
Igf1  (insulin-like growth factor 1)

Genes (Mus musculus)
Gh  (growth hormone)
Igf1  (insulin-like growth factor 1)

Genes (Homo sapiens)
GH1  (growth hormone 1)
IGF1  (insulin like growth factor 1)


Additional Information